Capacity and Share of Iranian Scientific Products in The Field of Medicinal Plants: An Opportunity to Treat Disease at the Time of a Drug Sanction: A Scientometric Study

Background and Aim: Iran is rich in species of medicinal plants, which are recognized as a necessity for public health. Investing in the production of science in this field is one of the valuable ways to develop and pay more attention to medicinal plants for the treatment of disease. Thus, the purpose of this study was to investigate the share of Iranian scientific products in the field of medicinal plants. Methods: The present study is a descriptive-analytical study using the scientometric method. Advanced search in the subject field of WOS and Scopus citation database with the keywords of complementary alternative medicine, traditional medicine, and medicinal herbs has been done to identify Iranian scientific products in the field of medicinal plants. The period of the present study was from 2010 to 2020 and the data were analyzed using Excel. Results: The share of Iranian scientific products in the field of medicinal plants in the Scopus database was 4.8 and in the WOS database was 5.5. The highest Iranian Scientific Cooperation with the united states in Scopus and WOS was 2.9 and 3.1, respectively. Also, Rafian Koopahi was the most productive writer with 3.2 in Scopus and 4.4% in Web of Science. Tehran University of Medical Sciences with 11.2 is the most productive organization in this field in Iran. Conclusion: However, opportunities such as the richness of medicinal plants and the recommendation of the World Health Organization; And challenges such as drug sanctions, the share of Iranian scientific products, is very small compared to Capacity. directing the production of science in this field requires investing in the elites in Owners, especially the military organs, which are most exposed to vulnerability, is a necessity. Also, cooperating with the leading East Asian countries.